ImmuCell Corporation (ICCC)
NASDAQ·Healthcare·Biotechnology
$8.38
+1.58%
Mkt Cap $58.62M
Next Earnings
In 14 daysTue, May 12, 2026
EPS Estimate
-$0.24
1 analysts
Revenue Estimate
$15.14M
Last quarter: missed by -720.00% on EPS, +41.20% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$58.62M
P/E
—
Fwd P/E
—
P/S
2.73
Rev TTM
—
EPS TTM
-$0.11